                         SEQUENCE LISTING

<110>  SEDERMA
 
<120>  USE OF A BACTERIAL EXTRACT FOR A COSMETIC OR DERMATOLOGICAL 
       TREATMENT, IN PARTICULAR A MOISTURIZING TREATMENT

<130>  ACYL PCT

<150>  FR1756882
<151>  2017-07-20

<160>  25    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  1

Arg Ser Arg Lys 
1               


<210>  2
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  2

Gly Gln Pro Arg 
1               


<210>  3
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  3

Lys Thr Phe Lys 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  4

Lys Thr Ala Lys 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  5

Lys Ala Tyr Lys 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  6

Lys Phe Tyr Lys 
1               


<210>  7
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  7

Lys Thr Thr Lys Ser 
1               5   


<210>  8
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  Synthetic peptide

<400>  8

Gly Lys Thr Thr Lys Ser 
1               5       


<210>  9
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  9

Val Gly Val Ala Pro Gly 
1               5       


<210>  10
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  10

Gly Gln Pro Arg 
1               


<210>  11
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  11

Lys Thr Phe Lys 
1               


<210>  12
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl or Palmitoyl chain on the N terminal end

<400>  12

Lys Thr Phe Lys 
1               


<210>  13
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  13

Lys Thr Ala Lys 
1               


<210>  14
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  14

Lys Ala Tyr Lys 
1               


<210>  15
<211>  4
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Elaidoyl chain on the N terminal end

<400>  15

Lys Phe Tyr Lys 
1               


<210>  16
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  16

Lys Thr Thr Lys Ser 
1               5   


<210>  17
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa being either a Proline P or a Leucine L.

<400>  17

Tyr Gly Gly Phe Xaa 
1               5   


<210>  18
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  18

Val Gly Val Ala Pro Gly 
1               5       


<210>  19
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<400>  19

Gly Lys Thr Thr Lys Ser 
1               5       


<210>  20
<211>  6
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  amidation by a Palmitoyl chain on the N terminal end

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa being Trp, Phe, Tyr, Tic, 7-hydroxy-Tic or Tpi

<400>  20

His Leu Asp Ile Ile Xaa 
1               5       


<210>  21
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  Acetylation on the N-terminal end

<400>  21

Glu Glu Met Gln Arg Arg 
1               5       


<210>  22
<211>  5
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  22

Tyr Ala Gly Phe Leu 
1               5   


<210>  23
<211>  4
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  23

Ala His Ser His 
1               


<210>  24
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  24

Ser Ile Lys Val Ala Val 
1               5       


<210>  25
<211>  6
<212>  PRT
<213>  artificial sequence

<220>
<223>  synthetic peptide

<400>  25

Gly Pro Gln Gly Pro Gln 
1               5       


